A FIXED−SEQUENCE, TWO−PERIOD, OPEN−LABEL DRUG−DRUG INTERACTION STUDY TO ASSESS THE EFFECT OF AN INHIBITOR OF CYTOCHROME P450 ISOENZYME 3A4 AND PERMEABILITY GLYCOPROTEIN 1 ON THE PHARMACOKINETICS OF TD−1211: